ro 5-4864 has been researched along with Malignant Melanoma in 2 studies
4'-chlorodiazepam: selectively binds peripheral benzodiazepine receptor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dourlat, J | 1 |
| Liu, WQ | 1 |
| Gresh, N | 1 |
| Garbay, C | 1 |
| Yue, YY | 1 |
| Wang, YC | 1 |
| Liao, ZX | 1 |
| Hu, FY | 1 |
| Liu, QY | 1 |
| Dong, J | 1 |
| Zhong, M | 1 |
| Chen, MH | 1 |
| Pan, YM | 1 |
| Zhong, H | 1 |
| Shang, J | 1 |
2 other studies available for ro 5-4864 and Malignant Melanoma
| Article | Year |
|---|---|
Novel 1,4-benzodiazepine derivatives with antiproliferative properties on tumor cell lines.
Topics: Antineoplastic Agents; Benzodiazepines; Benzodiazepinones; Cell Line, Tumor; Cell Proliferation; Che | 2007 |
Peripheral benzodiazepine receptor TSPO needs to be reconsidered before using as a drug target for a pigmentary disorder.
Topics: Adaptor Proteins, Signal Transducing; Animals; Benzodiazepinones; Humans; Ligands; Melanins; Melanom | 2022 |